Board declared a quarterly cash dividend of $0.36 per share, payable Dec 31, 2026 to holders of record Dec 15; director Lund retiring in… Plus members following SCI get this by push and email at 15:19:22 ET - it reached us 28 seconds after publication. Written by…
lincolnjournal.com Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Sorry, an error occurred. Account processing issue - the email address may already exist Must be at least 8 characters, not…
TradingView Accuray Incorporated (ARAY) Approves 1-for-40 Reverse Split to Address Nasdaq Listing Compliance Accuray approved a 1-for-40 reverse split, effective November 9, 2026. Outstanding shares will decrease from approximately 120.2M to approximately 3.0M; the split aims to help regain Nasdaq minimum-bid-price compliance. Context by…
Jindalee Lithium (ASX:JLL) is targeting a Nasdaq listing for its McDermitt Lithium Project in Oregon, US, during the December quarter after its US registration statement took effect. The US Securities and Exchange Commission (SEC) declared effective the Form S-4 filed…
Accuray announced on November 4, 2026 that its board had approved a 1-for-40 reverse stock split, intending to increase the common stock’s per-share trading price and enable the company to regain compliance with the Nasdaq Capital Market’s minimum bid-price requirement. The Form…
Supernus closed Indivior merger; legacy Indivior holders own 56.5%, $1.0B special dividend funded by $650M Citibank loan plus cash. Plus members following SUPN get this by push and email at 09:18:46 ET - it reached us under a second after publication. Across the 22 sessions after…
Orphan-drug exclusivity provides seven years of market exclusivity for ONAPGO Additionally, the Company submitted an sNDA to the FDA for a second supplier for ONAPGO, with potential approval by mid-year 2027 ROCKVILLE, Md., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Supernus, Inc. (NASDAQ:SUPN), a biopharmaceutical…
Director Gemayel disposed of 27,277 shares and all options in merger with Indivior at 1.5401 exchange ratio; no open-market sale. Plus members following SUPN get this by push and email at 16:42:53 ET - it reached us 29 seconds after publication. Georges Gemayel (director at…
Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. UBS initiated coverage on Solid Biosciences with a new price target…
Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. RBC Capital Mkts initiated coverage on Solid Biosciences with a new…
Biotechnology, gene editing, biopharma platforms, and clinical pipelines.
An article joins this feed when it matches these terms. Each one is also a search of its own.